vs

Side-by-side financial comparison of American Homes 4 Rent (AMH) and AdvanSix Inc. (ASIX). Click either name above to swap in a different company.

American Homes 4 Rent is the larger business by last-quarter revenue ($455.0M vs $359.9M, roughly 1.3× AdvanSix Inc.). American Homes 4 Rent runs the higher net margin — 31.7% vs -0.8%, a 32.5% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 4.2%). American Homes 4 Rent produced more free cash flow last quarter ($823.7M vs $36.1M). Over the past eight quarters, American Homes 4 Rent's revenue compounded faster (3.6% CAGR vs 3.4%).

American Homes 4 Rent, doing business as AMH, is a real estate investment trust based in Las Vegas, Nevada, that invests in single-family rental homes. As of December 31, 2019, the company owned 52,552 homes in 22 states. Its largest concentrations are in Atlanta, Dallas-Fort Worth, and Charlotte, North Carolina.

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

AMH vs ASIX — Head-to-Head

Bigger by revenue
AMH
AMH
1.3× larger
AMH
$455.0M
$359.9M
ASIX
Growing faster (revenue YoY)
ASIX
ASIX
+5.2% gap
ASIX
9.4%
4.2%
AMH
Higher net margin
AMH
AMH
32.5% more per $
AMH
31.7%
-0.8%
ASIX
More free cash flow
AMH
AMH
$787.6M more FCF
AMH
$823.7M
$36.1M
ASIX
Faster 2-yr revenue CAGR
AMH
AMH
Annualised
AMH
3.6%
3.4%
ASIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMH
AMH
ASIX
ASIX
Revenue
$455.0M
$359.9M
Net Profit
$144.3M
$-2.8M
Gross Margin
7.6%
Operating Margin
-0.7%
Net Margin
31.7%
-0.8%
Revenue YoY
4.2%
9.4%
Net Profit YoY
0.3%
-892.9%
EPS (diluted)
$0.33
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMH
AMH
ASIX
ASIX
Q4 25
$455.0M
$359.9M
Q3 25
$478.5M
$374.5M
Q2 25
$457.5M
$410.0M
Q1 25
$459.3M
$377.8M
Q4 24
$436.6M
$329.1M
Q3 24
$445.1M
$398.2M
Q2 24
$423.5M
$453.5M
Q1 24
$423.6M
$336.8M
Net Profit
AMH
AMH
ASIX
ASIX
Q4 25
$144.3M
$-2.8M
Q3 25
$116.8M
$-2.6M
Q2 25
$123.6M
$31.4M
Q1 25
$128.7M
$23.3M
Q4 24
$143.9M
$352.0K
Q3 24
$87.6M
$22.3M
Q2 24
$108.5M
$38.9M
Q1 24
$128.1M
$-17.4M
Gross Margin
AMH
AMH
ASIX
ASIX
Q4 25
7.6%
Q3 25
6.8%
Q2 25
14.3%
Q1 25
14.2%
Q4 24
3.4%
Q3 24
14.4%
Q2 24
17.9%
Q1 24
0.9%
Operating Margin
AMH
AMH
ASIX
ASIX
Q4 25
-0.7%
Q3 25
-0.9%
Q2 25
7.7%
Q1 25
7.7%
Q4 24
-3.9%
Q3 24
7.5%
Q2 24
11.5%
Q1 24
-7.0%
Net Margin
AMH
AMH
ASIX
ASIX
Q4 25
31.7%
-0.8%
Q3 25
24.4%
-0.7%
Q2 25
27.0%
7.7%
Q1 25
28.0%
6.2%
Q4 24
33.0%
0.1%
Q3 24
19.7%
5.6%
Q2 24
25.6%
8.6%
Q1 24
30.2%
-5.2%
EPS (diluted)
AMH
AMH
ASIX
ASIX
Q4 25
$0.33
$-0.11
Q3 25
$0.27
$-0.10
Q2 25
$0.28
$1.15
Q1 25
$0.30
$0.86
Q4 24
$0.33
$0.02
Q3 24
$0.20
$0.82
Q2 24
$0.25
$1.43
Q1 24
$0.30
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMH
AMH
ASIX
ASIX
Cash + ST InvestmentsLiquidity on hand
$108.5M
$19.8M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$7.0B
$815.2M
Total Assets
$13.2B
$1.7B
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMH
AMH
ASIX
ASIX
Q4 25
$108.5M
$19.8M
Q3 25
$45.6M
$23.7M
Q2 25
$323.3M
$18.4M
Q1 25
$69.7M
$8.3M
Q4 24
$199.4M
$19.6M
Q3 24
$162.5M
$17.3M
Q2 24
$718.4M
$12.1M
Q1 24
$124.8M
$20.6M
Total Debt
AMH
AMH
ASIX
ASIX
Q4 25
$5.1B
Q3 25
$4.8B
Q2 25
$5.2B
Q1 25
$4.9B
Q4 24
$5.0B
Q3 24
$4.5B
Q2 24
$5.0B
Q1 24
$4.5B
Stockholders' Equity
AMH
AMH
ASIX
ASIX
Q4 25
$7.0B
$815.2M
Q3 25
$7.2B
$818.2M
Q2 25
$7.2B
$823.7M
Q1 25
$7.2B
$794.4M
Q4 24
$7.2B
$774.6M
Q3 24
$7.0B
$766.4M
Q2 24
$7.0B
$746.6M
Q1 24
$7.0B
$713.2M
Total Assets
AMH
AMH
ASIX
ASIX
Q4 25
$13.2B
$1.7B
Q3 25
$13.3B
$1.7B
Q2 25
$13.6B
$1.6B
Q1 25
$13.3B
$1.6B
Q4 24
$13.4B
$1.6B
Q3 24
$12.8B
$1.5B
Q2 24
$13.3B
$1.5B
Q1 24
$12.8B
$1.5B
Debt / Equity
AMH
AMH
ASIX
ASIX
Q4 25
0.72×
Q3 25
0.68×
Q2 25
0.72×
Q1 25
0.69×
Q4 24
0.70×
Q3 24
0.64×
Q2 24
0.71×
Q1 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMH
AMH
ASIX
ASIX
Operating Cash FlowLast quarter
$864.3M
$63.7M
Free Cash FlowOCF − Capex
$823.7M
$36.1M
FCF MarginFCF / Revenue
181.0%
10.0%
Capex IntensityCapex / Revenue
8.9%
7.7%
Cash ConversionOCF / Net Profit
5.99×
TTM Free Cash FlowTrailing 4 quarters
$1.5B
$6.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMH
AMH
ASIX
ASIX
Q4 25
$864.3M
$63.7M
Q3 25
$223.3M
$26.6M
Q2 25
$271.9M
$21.1M
Q1 25
$223.4M
$11.4M
Q4 24
$811.5M
$64.2M
Q3 24
$233.6M
$57.3M
Q2 24
$274.0M
$50.2M
Q1 24
$201.8M
$-36.2M
Free Cash Flow
AMH
AMH
ASIX
ASIX
Q4 25
$823.7M
$36.1M
Q3 25
$214.5M
$66.0K
Q2 25
$257.7M
$-7.2M
Q1 25
$215.9M
$-22.6M
Q4 24
$777.5M
$29.8M
Q3 24
$225.3M
$26.8M
Q2 24
$263.3M
$16.7M
Q1 24
$191.0M
$-71.6M
FCF Margin
AMH
AMH
ASIX
ASIX
Q4 25
181.0%
10.0%
Q3 25
44.8%
0.0%
Q2 25
56.3%
-1.7%
Q1 25
47.0%
-6.0%
Q4 24
178.1%
9.1%
Q3 24
50.6%
6.7%
Q2 24
62.2%
3.7%
Q1 24
45.1%
-21.3%
Capex Intensity
AMH
AMH
ASIX
ASIX
Q4 25
8.9%
7.7%
Q3 25
1.8%
7.1%
Q2 25
3.1%
6.9%
Q1 25
1.6%
9.0%
Q4 24
7.8%
10.4%
Q3 24
1.9%
7.7%
Q2 24
2.5%
7.4%
Q1 24
2.6%
10.5%
Cash Conversion
AMH
AMH
ASIX
ASIX
Q4 25
5.99×
Q3 25
1.91×
Q2 25
2.20×
0.67×
Q1 25
1.74×
0.49×
Q4 24
5.64×
182.29×
Q3 24
2.67×
2.57×
Q2 24
2.52×
1.29×
Q1 24
1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMH
AMH

Segment breakdown not available.

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

Related Comparisons